Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04112186
NA

Mindfulness-Oriented Recovery Enhancement (MORE) in Heroin Addiction

Sponsor: Icahn School of Medicine at Mount Sinai

View on ClinicalTrials.gov

Summary

In this study, neuroimaging of reward processing, drug cue reactivity and inhibitory control is used before and immediately after 8 weeks of two types of group therapy in individuals with opioid addiction; clinical outcomes will be assessed before, immediately and three months after treatment. Results could point to factors that track and predict recovery with treatment, offering clinicians markers that can be used for enhancing precision medicine with the goal of reducing morbidity and mortality associated with opiate addiction.

Official title: Neuroimaging Response Inhibition and Salience Attribution Changes During Mindfulness-based Treatment of Human Heroin Addiction

Key Details

Gender

All

Age Range

18 Years - 64 Years

Study Type

INTERVENTIONAL

Enrollment

157

Start Date

2020-06-21

Completion Date

2031-03-31

Last Updated

2025-07-03

Healthy Volunteers

Yes

Interventions

BEHAVIORAL

Behavioral group therapy #1

Participants will participate in an 8-weeks of group therapy that uses psychological principles including mindfulness training, and could help decrease cravings for heroin and increase general well-being.

BEHAVIORAL

Behavioral group therapy #2

Participants will participate in an 8-weeks of group therapy that uses psychological principles (but not including mindfulness training) and could help decrease craving for heroin and increase general well-being.

Locations (1)

Icahn School of Medicine at Mount Sinai

New York, New York, United States